Targeting the Bcl-2 family for cancer therapy-Reference-Cited by-同舟云学术

Targeting the Bcl-2 family for cancer therapy

Published:2012-11-22 Issue:1 Volume:17 Page:61-75
ISSN:1472-8222
Container-title:Expert Opinion on Therapeutic Targets
language:en
Short-container-title:Expert Opinion on Therapeutic Targets

Author:

Thomas Shibu,Quinn Bridget A,Das Swadesh K,Dash Rupesh,Emdad Luni,Dasgupta Santanu,Wang Xiang-Yang,Dent Paul,Reed John C,Pellecchia Maurizio,Sarkar Devanand,Fisher Paul B

Publisher

Informa Healthcare

Subject

Clinical Biochemistry,Drug Discovery,Pharmacology,Molecular Medicine

Link

http://www.tandfonline.com/doi/pdf/10.1517/14728222.2013.733001

Reference139 articles.

1. Genetic control of programmed cell death in the nematode C. elegans

2. Cloning the chromosomal breakpoint of t(14;18) human lymphomas: clustering around Jh on chromosome 14 and near a transcriptional unit on 18

3. Cloning and structural analysis of cDNAs for bcl-2 and a hybrid bcl-2/immunoglobulin transcript resulting from the t(14;18) translocation

4. Involvement of the bcl -2 Gene in Human Follicular Lymphoma

5. Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells

Cited by 221 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prediction of drug targets related to HCC metastasis from the perspective of programmed cell death based on transformer;Future Generation Computer Systems;2024-11

2. Synthesis and Characterization of Magnetic Stearic Acid Modified Sulfated Alginate and Investigation of the Cytotoxicity and Apoptosis in MCF-7 Cell Line;Journal of Polymers and the Environment;2024-09-04

3. Targeted Inhibition of the PI3K/Akt/mTOR Signaling Axis: Potential for Sarcoma Therapy;Mini-Reviews in Medicinal Chemistry;2024-09

4. Resveratrol mediated the proliferation and apoptosis of gastric cancer cells by modulating the PI3K/Akt/P53 signaling pathway;Biochemical and Biophysical Research Communications;2024-09

5. Therapeutic Antisense Oligonucleotides in Oncology: From Bench to Bedside;Cancers;2024-08-23